As of 2025-12-28, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (20.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -178.9%.
The range of the Relative Valuation is (8.41) - (31.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.8x - 14.4x | 9.1x |
| Forward P/E multiples | 3.8x - 14.7x | 9.2x |
| Fair Price | (8.41) - (31.79) | (20.20) |
| Upside | -132.9% - -224.2% | -178.9% |
| Date | P/E |